These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8961919)
1. Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus: comment on the article by Esdaile et al. Smeenk RJ; Aarden LA; Swaak TJ Arthritis Rheum; 1996 Dec; 39(12):2083-5. PubMed ID: 8961919 [No Abstract] [Full Text] [Related]
2. Laboratory abnormalities and systemic lupus erythematosus flare: comment on the article by Esdaile et al. Zonana-Nacach A; Sánchez L; Camargo-Coronel A; Martínez-Osuna P; Jimenez-Balderas FJ Arthritis Rheum; 1997 Nov; 40(11):2092-3; author reply 2093-5. PubMed ID: 9365101 [No Abstract] [Full Text] [Related]
3. The rarity of antinuclear antibody negativity in systemic lupus erythematosus: comment on the article by Merrill et al. Major GA Arthritis Rheum; 2011 Apr; 63(4):1157-8; author reply 1158. PubMed ID: 21452333 [No Abstract] [Full Text] [Related]
4. Laboratory tests as predictors of flares in systemic lupus erythematosus: comment on the article by Esdaile et al. Kallenberg CG; Bootsma H; Spronk PE; ter Borg EJ; Derksen RH; Kater L Arthritis Rheum; 1997 Feb; 40(2):393-4. PubMed ID: 9041957 [No Abstract] [Full Text] [Related]
5. Antibodies to dsDNA in drug induced lupus erythematosus. Cohen MG J Rheumatol; 1994 Mar; 21(3):578-9. PubMed ID: 8006909 [No Abstract] [Full Text] [Related]
6. Up regulation of serum tumor necrosis factor-related apoptosis inducing ligand in juvenile-onset systemic lupus erythematosus: relations with disease activity, antibodies to double -stranded DNA, nephritis and neutropenia. Ezzat MH; El-Gammasy TM; Shaheen KY; El-Mezdawi RA; Youssef MS Int J Rheum Dis; 2013 Jun; 16(3):310-8. PubMed ID: 23981753 [TBL] [Abstract][Full Text] [Related]
7. Associations of the Levels of C4d-bearing Reticulocytes and High-avidity Anti-dsDNA Antibodies with Disease Activity in Systemic Lupus Erythematosus. Mora C; Medina-Rosas J; Santos AM; Jaimes DA; Arbeláez AM; Romero C; Cortes A; Londono J J Rheumatol; 2016 Sep; 43(9):1657-64. PubMed ID: 27134246 [TBL] [Abstract][Full Text] [Related]
8. [The clinical and diagnostic value of detection of antinuclear factor, antibodies to double-helical DNA and cardiolipin in patients with systemic lupus erythematosus]. Sozina AV; Ilivanova EP; Shul'man AM; Shul'man MA; Shemerovskaia TG; Lapin SV; Totolian AA Klin Lab Diagn; 2008 May; (5):44-7. PubMed ID: 18590168 [No Abstract] [Full Text] [Related]
10. New Perspectives in Rheumatology: Biomarkers as Entry Criteria for Clinical Trials of New Therapies for Systemic Lupus Erythematosus: The Example of Antinuclear Antibodies and Anti-DNA. Pisetsky DS; Rovin BH; Lipsky PE Arthritis Rheumatol; 2017 Mar; 69(3):487-493. PubMed ID: 27899010 [No Abstract] [Full Text] [Related]
11. Paradigm shift in antinuclear antibody negative lupus: Current evidence. Tiwary AK; Kumar P Indian J Dermatol Venereol Leprol; 2018; 84(4):384-387. PubMed ID: 29637910 [No Abstract] [Full Text] [Related]
12. Patient variation in the correlation between laboratory abnormalities and future lupus flares: comment on the article by Esdaile et al. Ng WL; Kung NN; Choi HY Arthritis Rheum; 1997 Nov; 40(11):2093-5. PubMed ID: 9365102 [No Abstract] [Full Text] [Related]
13. Systemic lupus erythematosus: an update on treat-to-target. Roberts AL; Rizzolo D JAAPA; 2015 Sep; 28(9):22-8. PubMed ID: 26251978 [TBL] [Abstract][Full Text] [Related]
14. The predictive value of ANA and anti-dsDNA antibodies for flares in SLE. Bizzaro N; Villalta D Rheumatology (Oxford); 2001 Dec; 40(12):1422-3. PubMed ID: 11752520 [No Abstract] [Full Text] [Related]
15. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials. Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW; Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628 [TBL] [Abstract][Full Text] [Related]
16. 50 Years Ago in TheJournalofPediatrics: DNA Antibody Testing for Childhood Systemic Lupus Erythematosus (cSLE): Going Far(r). Ashkenazi L; Hashkes PJ J Pediatr; 2021 Jun; 233():104. PubMed ID: 34030830 [No Abstract] [Full Text] [Related]
17. ROC analysis comparison of three assays for the detection of antibodies against double-stranded DNA in serum for the diagnosis of systemic lupus erythematosus. Wasmuth JC; Grün B; Terjung B; Homrighausen A; Spengler U Clin Chem; 2004 Nov; 50(11):2169-71. PubMed ID: 15502090 [No Abstract] [Full Text] [Related]
18. [The new classification criteria for systemic lupus erythematosus (SLICC)]. Costedoat-Chalumeau N; Francès C; Pouchot J; Piette JC Rev Med Interne; 2014 Aug; 35(8):487-90. PubMed ID: 24467799 [No Abstract] [Full Text] [Related]
19. Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis. Jaekell HP; Trabandt A; Grobe N; Werle E Lupus; 2006; 15(6):335-45. PubMed ID: 16830879 [TBL] [Abstract][Full Text] [Related]
20. Double stranded DNA antibody estimation for the diagnosis of systematic lupus erythematosus [corrected]. Mohanalingam U; Mathai E; Sridharan G Indian J Pathol Microbiol; 1993 Jul; 36(3):265-7. PubMed ID: 8093130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]